Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 2/2018

01-02-2018 | Original Contributions

Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease

Authors: Ahmed Talha, Mohammed Ibrahim

Published in: Obesity Surgery | Issue 2/2018

Login to get access

Abstract

Background

Gastroesophageal reflux disease (GERD) is commonly associated with obesity, and its surgical management is debatable.

Objective

The objective of this study was to prove the safety and feasibility of laparoscopic Nissen’s fundoplication (LNF) combined with mid-gastric plication (MGP) for treatment of obese patients with GERD.

Methods

LNF combined with MGP was done for 18 patients. All interventions were performed under general anesthesia. The follow-up protocol included body mass index (BMI), percentage of excess weight loss (%EWL), percentage of excess BMI loss (%EBMIL), and clinical assessment using the Gastro-esophageal Reflux Health-Related Quality-of-Life (GERD-HRQOL) scale at 6 and 12 months.

Results

The period of follow-up ranged from 12 to 33 months with a mean of 17.74 ± 3.73 months. The operation time was 1.40 ± 0.27 h. No serious procedure-related complications occurred. GERD-related symptoms resolved in all patients (p < 0.001). There was a significant improvment in endoscopic findings at 6 months compared to properatively (p = 0.001). There was a significant patient satisfaction score using GERD-HRQOL at 6 and 12 months (p = 0.000). The 1-year follow-up excess weight was significantly less than the baseline excess weight (p < 0.001). The average BMI decreased from 37.59 ± 1.89 kg/m2 at baseline to 30.61 ± 1.57 kg/m2 at 1 year (p < 0.001).

Conclusions

LNF combined with MGP for treatment of obese patients with GERD is technically safe, feasible, and promising with no serious procedure-related complications. The technique is effective in terms of weight loss and cure of GERD. However, future larger studies are required to demonstrate the safety, effectiveness, and long-term durability of the procedure.
Literature
1.
Oh DS, DeMeester SR, Vallbohmer D, et al. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett’s esophagus with antireflux surgery. Arch Surg. 2007;142:554–60.CrossRefPubMed
2.
Bu X, Ma Y, Der R, et al. Body mass index is associated with Barrett’s esophagus and cardiac mucosal metaplasia. Dig Dis Sci. 2006;51:1589–94.CrossRefPubMed
3.
Santonicola A, Angrisani L, Cutolo P, et al. The effect of laparoscopic sleeve gastrectomy with or without hiatal hernia repair on gastroesophageal reflux disease in obese patients. Surg Obes Relat Dis. 2014;10(2):250–5.CrossRefPubMed
4.
Merrouche M, Sabaté JM, Jouet P, et al. Gastroesophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg. 2007;17:894–900.CrossRefPubMed
5.
Korenkov M, Köhler L, Yücel N, et al. Esophageal motility and reflux symptoms before and after bariatric surgery. Obes Surg. 2002;12:72–6.CrossRefPubMed
6.
Rebecchi F, Rocchietto S, Giaccone C, et al. Gastroesophageal reflux disease and esophageal motility in morbidly obese patients submitted to laparoscopic adjustable silicone gastric banding or laparoscopic vertical banded gastroplasty. Surg Endosc. 2011;25(3):795–803.CrossRefPubMed
7.
Patti MG. An evidence-based approach to the treatment of gastroesophageal reflux disease. JAMA Surg. 2016;151(1):73–8.CrossRefPubMed
8.
Varela JE, Hinojosa MW, Nguyen NT. Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2009;5:139–43.CrossRefPubMed
9.
Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoend Adv Surg Tech. 2007;17(6):793–8.CrossRef
10.
Kourkoulos M, Giorgakis E, Kokkinos C, et al. Laparoscopic gastric plication for the treatment of morbid obesity: a review. Hindawi Publishing Corporation. Minim Invasive Surg, Article ID. 2012:696348, 7 pages. doi:10.​1155/​2012/​696348.
11.
Rickenbacher N, Kötter T, Kochen MM, et al. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014;28(1):143–55.CrossRefPubMed
12.
Velanovich V, Vallance SR, Gusz JR, et al. Quality-of-life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217–24.PubMed
13.
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.CrossRefPubMedPubMedCentral
14.
Gianos M, Abdemur A, Fendrich I, et al. Outcomes of bariatric surgery in patients with body mass index <35 kg/m2. Surg Obes Relat Dis. 2012;8(1):25–30.CrossRefPubMed
15.
ASMBS statements/guidelines. Bariatric surgery in class I obesity (body mass index 30–35 kg/m2) ASMBS Clinical Issues Committee. Surg Obes Related Dis. 2013;9:e1–e10.CrossRef
16.
Noun R, Chakhtoura G, Nasr M, Skaff J, Choucair N, Rkaybi N, Tohme-Noun C. Laparoscopic sleeve gastrectomy for mildly obese patients (body mass index of 30 <35 kg/m2): operative outcome and short-term results. J Obes 2012, Article ID 813650, 5 pages doi:10.​1155/​2012/​813650.
17.
18.
Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis. 2013;9:398–404.CrossRefPubMed
19.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211.CrossRefPubMed
20.
21.
Lee WJ, Han ML, Ser KH, et al. Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results. Obes Surg. 2014;24(9):1447–52.CrossRefPubMed
22.
Lomanto D, Lee WJ, Goel R, et al. Bariatric surgery in Asia in the last 5 years (2005 – 2009). Obes Surg. 2012;22:502–6.CrossRefPubMed
23.
24.
Naik RD, Choksi YA, Vaezi MF. Impact of weight loss surgery on esophageal physiology. Gastroenterol Hepatol. 2015;11(12):801–9.
25.
26.
Soricelli E, Iossa A, Casella G, et al. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg Obes Relat Dis. 2013;9:356–61.CrossRefPubMed
27.
DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 2014;149:328–34.CrossRefPubMed
28.
Sharma A, Aggarwal S, Ahuja V, et al. Evaluation of gastroesophageal reflux before and after sleeve gastrectomy using symptom scoring, scintigraphy, and endoscopy. Surg Obes Relat Dis. 2014;10:600–5.CrossRefPubMed
29.
Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260:909–14. discussion 914–5CrossRefPubMed
30.
Daes J, Jimenez ME, Said N, et al. Improvement of gastroesophageal reflux symptoms after standardized laparoscopic sleeve gastrectomy. Obes Surg. 2014;24:536–40.CrossRefPubMed
31.
Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10:502–7.CrossRefPubMed
32.
Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22:764–72.CrossRefPubMed
33.
EL-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what we really learned? Surg Endosc. 2012;26(10):2789–96.CrossRefPubMed
34.
Paroz A, Calmes JM, Giusti V. Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a continuous challenge in bariatric surgery. Obes Surg. 2006;16:1482–7.CrossRefPubMed
35.
Gasteyger C, Suter M, Gaillard RC, et al. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr. 2008;87:1128–33.PubMed
36.
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini- gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRefPubMed
37.
Gutschow CA, Collet P, Prenzel K, et al. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg. 2005;9(7):941–8.CrossRefPubMed
38.
Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 1981;116:602–5.CrossRefPubMed
39.
Niazi M, Maleki AR, Talebpour M. Short-term outcomes of laparoscopic gastric plication in morbidly obese patients: importance of postoperative follow-up. Obes Surg. 2013;23:87–92.CrossRefPubMed
40.
Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg. 2011;21:1657–63.CrossRefPubMed
41.
Huang CK, Asim S, Lo CH. Augmenting weight loss after laparoscopic adjustable gastric banding by laparoscopic gastric plication. Surg Obes Relat Dis. 2011;7:235–6.CrossRefPubMed
42.
Huang CK, Lo CH, Shabbir A, et al. Novel bariatric technology: laparoscopic adjustable gastric banded plication: technique and preliminary results. Surg Obes Relat Dis. 2012;8:41–7.CrossRefPubMed
43.
De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57–61.CrossRefPubMed
44.
Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care. 2005;28:481–4.CrossRefPubMed
45.
Brethauer SA, Harris JL, Kroh M, et al. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis. 2011;7:15–22.CrossRefPubMed
46.
Ospanov O, Maleckas A, Orekeshova A. Gastric greater curvature plication combined with Nissen fundoplication in the treatment of gastroesophageal reflux disease and obesity. Medicina. 2016;52:283–90.CrossRefPubMed
47.
Frantzides CT, Carlson MA, Madan AK, et al. Selective use of esophageal manometry and 24-hour pH monitoring before laparoscopic fundoplication. J Am Coll Surg. 2003;197:358–63. discussion 354–63CrossRefPubMed
48.
Yang H, Watson DI, Kelly J, et al. Esophageal manometry and clinical outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg. 2007;11:1126–33.CrossRefPubMed
49.
Fibbe C, Layer P, Keller J, et al. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology. 2001;121:5–14.CrossRefPubMed
Metadata
Title
Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease
Authors
Ahmed Talha
Mohammed Ibrahim
Publication date
01-02-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 2/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2862-8

Other articles of this Issue 2/2018

Obesity Surgery 2/2018 Go to the issue

Original Contributions

Safety and Efficacy of a New Swallowable Intragastric Balloon Not Needing Endoscopy: Early Italian Experience

Original Contributions

The Socio-economic Impact of Bariatric Surgery

Brief Communication

Patients’ Reported Usage of Weight Management Skills Following Bariatric Surgery

Original Contributions

Bile Gastritis Following Laparoscopic Single Anastomosis Gastric Bypass: Pilot Study to Assess Significance of Bilirubin Level in Gastric Aspirate

Original Contributions

Mandatory Risk Assessment Reduces Venous Thromboembolism in Bariatric Surgery Patients

Original Contributions

Influence of Patient Choice on Outcome of Bariatric Surgery